Celebrex for Breast Cancer
By Brianna McFadden
Recently, several studies have shown that there may be benefits from Celebrex for breast cancer. An arthritis treatment drug, Celebrex has been making strides lately as a preventative treatment option for breast cancer. Women taking Celebrex for breast cancer for an extended period of time have been shown to be 71% less likely to develop breast cancer.
Celebrex for Breast Cancer
Celebrex for breast cancer is believed to work by suppressing inflammation. In certain cancers, th1s inflammation is believed to play a critical developmental role. If Celebrex for breast cancer removes the inflammation then there is a less likely chance the cancer will develop.
Celebrex for breast cancer may also work by lowering the levels of estrogen receptors, wh1ch can signal cancer as a marker of cell reproduction. Th1s is another developmental-level cancer inh1bitor that Celebrex for breast cancer may be able to help with.
The possible benefits of Celebrex for breast cancer don’t end with prevention. According to Molecular Cancer Research magazine, Celebrex has been shown to shrink breast cancer tumours in mice by ramping up cancer cell death in the mice’s breast tissue. In order to do th1s, Celebrex for breast cancer increases levels of a cell death-fostering protein wh1le reducing the activity of a protein that is known to guard against cell death.
Scientists say that Celebrex for breast cancer requires more study and research before it can be recommended, citing that Cox-2 inh1bitors like Celebrex still carry many cardiovascular concerns.